United Therapeutics Corporation (UTHR) vs Zimmer Biomet Holdings, Inc. (ZBH)
A side-by-side comparison of United Therapeutics Corporation and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
UTHR
United Therapeutics Corporation
$494.63HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT
ZBH
Zimmer Biomet Holdings, Inc.
$95.36HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT
Total return — UTHR vs ZBH
growth of $100 · dividends reinvested · last 10yUTHR +313.8% (+15.3%/yr)ZBH -14.2% (-1.5%/yr)UTHR compounded faster over this window
UTHR ZBH
UTHR vs ZBH: by the numbers
- •UTHR is the larger company ($21.00B vs $18.45B market cap).
- •UTHR trades at the lower trailing earnings multiple (17.72 vs 23.20 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 9.48% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs 2.89% CAGR).
- •ZBH pays a dividend (1.01% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | UTHR | ZBH |
|---|---|---|
| P/E ratio | 17.72 | 23.20 |
| Forward P/E | 18.92 | 11.18 |
| P/S ratio | 6.66 | 2.17 |
| P/B ratio | 3.28 | 1.46 |
| EV / EBITDA | 12.84 | 10.91 |
| FCF yield | 5.21% | 6.90% |
Profitability
| Metric | UTHR | ZBH |
|---|---|---|
| Gross margin | 86.14% | 61.62% |
| Operating margin | 44.49% | 15.73% |
| Net margin | 41.56% | 9.48% |
| ROE | 20.48% | 6.39% |
| ROIC | 17.69% | 5.51% |
Dividends
| Metric | UTHR | ZBH |
|---|---|---|
| Dividend yield | N/A | 1.01% |
| Payout ratio | N/A | 23.36% |
Growth (annualized)
| Metric | UTHR | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 14.68% | 2.89% |
| EPS CAGR (5Y) | 20.93% | N/A |
| FCF CAGR (5Y) | 14.31% | 6.49% |
| Total return CAGR (5Y) | 19.17% | -6.74% |
Frequently asked
- Which has the lower trailing P/E, UTHR or ZBH?
- UTHR has the lower trailing P/E: UTHR trades at 17.72 and ZBH at 23.20. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, UTHR or ZBH?
- Over the past five years, UTHR grew revenue faster — UTHR at a 14.68% CAGR versus ZBH at 2.89%.
- Does UTHR or ZBH pay a bigger dividend?
- ZBH pays a dividend (1.01% yield), while UTHR has no payments in the available dividend history.
- Is UTHR or ZBH more profitable?
- UTHR runs the higher net margin — UTHR at 41.56% versus ZBH at 9.48%.
- How have UTHR and ZBH total returns compared?
- Over the past 10 years, UTHR delivered 15.50% and ZBH delivered -1.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
United Therapeutics P/E ratioZimmer Biomet P/E ratioZimmer Biomet dividend yieldUnited Therapeutics ROEZimmer Biomet ROEUnited Therapeutics operating marginZimmer Biomet operating marginUnited Therapeutics revenue growthZimmer Biomet revenue growthUnited Therapeutics free cash flowZimmer Biomet free cash flow
United Therapeutics & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.